Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer (CEPAFIRI)
This study has been completed.
Sponsor:
Institut Bergonié
Collaborators:
Novartis
Sanofi-Synthelabo
Aventis Pharmaceuticals
Information provided by:
Institut Bergonié
ClinicalTrials.gov Identifier:
NCT00210184
First received: September 13, 2005
Last updated: December 29, 2011
Last verified: October 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | July 2009 |
| Estimated Primary Completion Date: | No date given |